142 related articles for article (PubMed ID: 10488880)
1. A randomised trial of a Haemophilus influenzae type b conjugate vaccine in a developing country for the prevention of pneumonia--ethical considerations.
Mulholland K; Smith PG; Broome CV; Gaye A; Whittle H; Greenwood BM
Int J Tuberc Lung Dis; 1999 Sep; 3(9):749-55. PubMed ID: 10488880
[TBL] [Abstract][Full Text] [Related]
2. The impact of vaccines on pneumonia: key lessons from Haemophilus influenzae type b conjugate vaccines.
Gessner BD; Adegbola RA
Vaccine; 2008 Jun; 26 Suppl 2():B3-8. PubMed ID: 18793604
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness of Haemophilus influenzae b conjugate vaccine on childhood pneumonia: a case-control study in Brazil.
de Andrade AL; de Andrade JG; Martelli CM; e Silva SA; de Oliveira RM; Costa MS; Laval CB; Ribeiro LH; Di Fabio JL
Int J Epidemiol; 2004 Feb; 33(1):173-81. PubMed ID: 15075166
[TBL] [Abstract][Full Text] [Related]
4. Randomised trial of Haemophilus influenzae type-b tetanus protein conjugate vaccine [corrected] for prevention of pneumonia and meningitis in Gambian infants.
Mulholland K; Hilton S; Adegbola R; Usen S; Oparaugo A; Omosigho C; Weber M; Palmer A; Schneider G; Jobe K; Lahai G; Jaffar S; Secka O; Lin K; Ethevenaux C; Greenwood B
Lancet; 1997 Apr; 349(9060):1191-7. PubMed ID: 9130939
[TBL] [Abstract][Full Text] [Related]
5. Prevention of Haemophilus influenzae type b disease: past success and future challenges.
Chandran A; Watt JP; Santosham M
Expert Rev Vaccines; 2005 Dec; 4(6):819-27. PubMed ID: 16372878
[TBL] [Abstract][Full Text] [Related]
6. The Gambian Haemophilus influenzae type b vaccine trial: what does it tell us about the burden of Haemophilus influenzae type b disease?
Mulholland EK; Adegbola RA
Pediatr Infect Dis J; 1998 Sep; 17(9 Suppl):S123-5. PubMed ID: 9781744
[TBL] [Abstract][Full Text] [Related]
7. The development of a new heptavalent diphtheria-tetanus-whole cell pertussis-hepatitis B-Haemophilus influenzae type b-Neisseria meningitidis serogroups A and C vaccine: a randomized dose-ranging trial of the conjugate vaccine components.
Gatchalian S; Palestroque E; De Vleeschauwer I; Han HH; Poolman J; Schuerman L; Dobbelaere K; Boutriau D
Int J Infect Dis; 2008 May; 12(3):278-88. PubMed ID: 17981067
[TBL] [Abstract][Full Text] [Related]
8. NTAGI subcommittee recommendations on Haemophilus influenzae type B (Hib) vaccine introduction in India.
Subcommittee on Introduction of Hib Vaccine in Universal Immunization Program, National Technical Advisory Group on Immunization, India
Indian Pediatr; 2009 Nov; 46(11):945-54. PubMed ID: 19955578
[TBL] [Abstract][Full Text] [Related]
9. Vaccine-preventable haemophilus influenza type B disease burden and cost-effectiveness of infant vaccination in Indonesia.
Gessner BD; Sedyaningsih ER; Griffiths UK; Sutanto A; Linehan M; Mercer D; Mulholland EK; Walker DG; Steinhoff M; Nadjib M
Pediatr Infect Dis J; 2008 May; 27(5):438-43. PubMed ID: 18398383
[TBL] [Abstract][Full Text] [Related]
10. Progress toward introduction of Haemophilus influenzae type b vaccine in low-income countries--worldwide, 2004-2007.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2008 Feb; 57(6):148-51. PubMed ID: 18272957
[TBL] [Abstract][Full Text] [Related]
11. Conjugate vaccines for preventing Haemophilus influenzae type b infections.
Swingler G; Fransman D; Hussey G
Cochrane Database Syst Rev; 2003; (4):CD001729. PubMed ID: 14583937
[TBL] [Abstract][Full Text] [Related]
12. Global status of Haemophilus influenzae type b and pneumococcal conjugate vaccines: evidence, policies, and introductions.
Levine OS; Knoll MD; Jones A; Walker DG; Risko N; Gilani Z
Curr Opin Infect Dis; 2010 Jun; 23(3):236-41. PubMed ID: 20407316
[TBL] [Abstract][Full Text] [Related]
13. The decline of Haemophilus influenzae type b disease in Australia.
Herceg A
Commun Dis Intell; 1997 Jun; 21(13):173-6. PubMed ID: 9222159
[TBL] [Abstract][Full Text] [Related]
14. High incidence of Haemophilus influenzae type b infection in children in Pacific island countries.
Russell FM; Carapetis JR; Mansoor O; Darcy A; Fakakovi T; Metai A; Potoi NT; Wilson N; Mulholland EK
Clin Infect Dis; 2003 Dec; 37(12):1593-9. PubMed ID: 14689337
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of vaccines to prevent childhood pneumonia: lessons relevant to planning tuberculosis vaccine trials.
Mulholland K
Clin Infect Dis; 2000 Jun; 30 Suppl 3():S206-9. PubMed ID: 10875784
[TBL] [Abstract][Full Text] [Related]
16. Immunogenicity and safety of four different doses of Haemophilus influenzae type b-tetanus toxoid conjugated vaccine, combined with diphtheria-tetanus-pertussis vaccine (DTP-Hib), in Indonesian infants.
Punjabi NH; Richie EL; Simanjuntak CH; Harjanto SJ; Wangsasaputra F; Arjoso S; Rofiq A; Prijanto M; Julitasari ; Yela U; Herzog C; Cryz SJ
Vaccine; 2006 Mar; 24(11):1776-85. PubMed ID: 16303216
[TBL] [Abstract][Full Text] [Related]
17. Pneumonia Prevention during a Humanitarian Emergency: Cost-effectiveness of Haemophilus Influenzae Type B Conjugate Vaccine and Pneumococcal Conjugate Vaccine in Somalia.
Gargano LM; Hajjeh R; Cookson ST
Prehosp Disaster Med; 2015 Aug; 30(4):402-11. PubMed ID: 26061190
[TBL] [Abstract][Full Text] [Related]
18. Haemophilus influenzae type b vaccine impact in resource-poor settings in Asia and Africa.
Gessner BD
Expert Rev Vaccines; 2009 Jan; 8(1):91-102. PubMed ID: 19093776
[TBL] [Abstract][Full Text] [Related]
19. Incidence of Haemophilus influenzae type b and other invasive diseases in South Korean children.
Kim JS; Jang YT; Kim JD; Park TH; Park JM; Kilgore PE; Kennedy WA; Park E; Nyambat B; Kim DR; Hwang PH; Kim SJ; Eun SH; Lee HS; Cho JH; Kim YS; Chang SJ; Huang HF; Clemens JD; Ward JI
Vaccine; 2004 Sep; 22(29-30):3952-62. PubMed ID: 15364444
[TBL] [Abstract][Full Text] [Related]
20. Endotoxin content in Haemophilus influenzae type b vaccine.
Ochiai M; Kataoka M; Toyoizumi H; Yamamoto A; Kamachi K; Arakawa Y; Kurata T; Horiuchi Y
Jpn J Infect Dis; 2004 Apr; 57(2):58-9. PubMed ID: 15118211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]